CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Krka DD Novo Mesto Company Snapshot
Krka DD Novo Mesto operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other pharmaceutical manufacturers in Europe: Recordati SpA of Italy (2017 sales of 1.29 billion Euro [US$1.46 billion] of which 84% was Pharmaceuticals), Vifor Pharma AG of Switzerland (1.34 billion Swiss Francs [US$1.34 billion] of which 100% was Pharmaceutical), and Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag which is based in Hungary (444.36 billion Hungarian Forints [US$1.58 billion] of which 80% was Pharmaceutical Manufacturing and Sale).

Sales Analysis. Krka DD Novo Mesto reported sales of 1.27 billion Euro (US$1.43 billion) for the year ending December of 2017. This represents an increase of 7.8% versus 2016, when the company's sales were 1.17 billion Euro. Sales of Eastern Europe saw an increase that was more than double the company's growth rate: sales were up 16.8% in 2017, from 332.29 million Euro to 388.22 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Krka DD Novo Mesto
  Stock Performance Chart for Krka DD Novo Mesto
 
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 57.60
(Figures in Euro)
1 Week 0.3%   13 Weeks -0.7%  
4 Weeks 5.9%   52 Weeks 1.1%  
 
Krka DD Novo Mesto Key Data:
  Ticker: KRKG Country: Slovenia
  Exchanges: LJB Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,266,392,000
(Year Ending Jan 2018).
Employees: 10,832
  Currency: Euro Market Cap: 1,841,700,902
  Fiscal Yr Ends: December Shares Outstanding: 31,973,974
  Share Type: Ordinary Closely Held Shares: 8,245,510
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.